Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yili Pharmaceutical, officially known as Xinjiang Yili Pharmaceutical Co., Ltd., is a Chinese pharmaceutical company based in the Xinjiang Uygur Autonomous Region. The company specializes in the research, development, and large-scale manufacturing of traditional Chinese medicine (TCM) and chemical drug formulations. Its product portfolio includes a wide range of antibiotics, cardiovascular medications, and respiratory treatments, often leveraging local botanical resources. Yili Pharmaceutical operates multiple GMP-certified production lines for tablets, capsules, and granules, serving both domestic and regional markets. The company is a key industrial player in Northwest China's healthcare sector, focusing on affordable essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yili Group Pharmaceutical.